Targeting immune checkpoints: releasing the restraints on anti-tumor immunity for patients with melanoma. [electronic resource]
Producer: 20120724Description: 153-9 p. digitalISSN:- 1540-336X
- Animals
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- B7-H1 Antigen -- antagonists & inhibitors
- CTLA-4 Antigen -- antagonists & inhibitors
- Combined Modality Therapy
- Humans
- Immunotherapy
- Ipilimumab
- Melanoma -- immunology
- Prognosis
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.